The following literature is available from Beckman Coulter. Some
resources are available online by clicking the icons below. Items that
are not available online can be ordered from Beckman Coulter
or through your local representative.
| View |
Title |
Order No. |
 |
Analytical Ultracentrifugation as a Contemporary Biomolecular Research Tool, J. Cole, J. Hansen, Journal of Biomolecular Techniques, Vol. 10, Issue 4, Dec. 1999 |
AR-8647A |
|
|
Applying Selective Biophysical Techniques in Assessing the Comparability of Protein Therapeutics--Case Studies. Yijia Jiang, PhD and Linda Owens Narhi, PhD, Amgen, Inc. American Pharmaceutical Review, Jul./Aug. 2006. |
AR-10229A |
|
|
Characterizing the Aggregation and Conformation of Protein Therapeutics, J. Philo, American Biotechnology Laboratory, Oct. 2003 |
AR-9663A |
|
|
MALDI Spotting on the Biomek® 3000 Enables Multidimensional Proteome Profiling, M. Cu, M. Simonian, E. Betgovargez, K. Roby, G. Threadgill, The Application Notebook, PharmaGenomics, Jun. 2004 |
AR-9949A(PL) |
|
|
Sedimentation for Success: Characterizing Small-Molecule/Protein Interactions by Sedimentation Analysis Helps Validate Lead Series Early in the Drug Discovery Process, M. Arkin, Modern Drug Discover, Nov. 2004 |
AR-9925A |
| View |
Title |
Order No. |
|
|
Mapping of Proteins from Cancer Cells Using PF 2D Liquid Fractionation and Mass Spec, by David Lubman, Ph.D. |
CD-9781A |
|
|
Quantifying Protein Aggregates by Sedimentation Velocity |
CD-10238A |
|
|
Sedimentation for Success: Characterizing Small Molecule/Protein Interactions by Sedimentation Equilibrium |
CD-9996A |
|
|
Understanding What Makes a Cancer Cell Malignant: The Beckman Coulter Proteomics System Dissects Protein Expression Differences, by Robert E. Hurst, Ph.D. |
CD-9657A |
|
|
Using ProteomeLab PF 2D Technology to Probe Glioma Biology, by Oliver Bogler, Ph. D. |
CD-9537B |
|
|
ProteomeLab PF 2D/IgY Bibliography |
SR-10546A |
| View |
Title |
Order No. |
|
|
Abundant-Protein Depletion Coupled with Multidimensional Fractionation of the Human Plasma Proteome |
P-9916A |
|
|
Advances in High Resolution Separation of Protein Conformations Using SDS-Capillary Gel Electrophoresis |
P-10740A |
|
|
Automated Strategies for Fractionating and Characterizing Proteomes |
P-9961A |
|
|
Multidimensional Fractionation and Characterization of the Bovine Skeletal Muscle Proteome by Two-Dimensional Liquid Fractionation and Capillary Gel Electrophoresis |
P-10284A |
|
|
Oligosaccharide Profiling of a Genetically Engineered HIV gp140 Envelope Glycoprotein |
P-10466A |
|
|
Optimizing Conditions to obtain Improved Resolution and Reproducibility in Capillary Isoelectric Focusing (cIEF) |
P-10286A |
|
|
Plasma/Serum Proteome Partitioning & Fractionation for Biomarker Discovery |
P-10019A |
|
|
ProteomeLab™ PA 800 Protein Characterization System -- Bridging Antibody Development and Therapeutic Product Quality Control |
P-10020A |
|
|
ProteomeLab™ PF 2D Analysis of Genetically-Characterized Human Glioma Xenografts |
P-9962A |
|
|
ProteomeLab™ XL-A/XL-I Protein Characterization System--Native Condition Protein Characterization |
P-10119B |
|
|
Proteomic Analysis of Soluble Proteins Enriched from Skeletal Muscle |
P-10285A |
|
|
Simplified and Automated Approach for Protein Identification Using Capillary Electrophoresis-Tandem Mass Spectrometry |
P-10165A |
|
|
Simplified and Automated Approach for Protein Identification Using Capillary Electrophoresis-Tandem Mass Spectrometry |
P-10287A |
|
|
The Two-Dimensional Protein Fractionation (PF 2D) Platform Facilitates a Comprehensive Mapping of Protein Expression Profiles in Activated and Non-Activated Peripheral Blood Mononuclear Cells |
P-9860A |
|
|
Two-Dimensional Chromatographic Proteome Profiling of Human Plasma |
P-9959A |
|
|
Using the Biomek® 3000 Laboratory Automation Workstation to Interface 2D Liquid Chromatography with Mass Spectrometry for Multidimensional Proteome Profiling |
P-9766A(PL) |
| View |
Title |
Order No. |
|
|
a-Chymotrypsin as Model System to Demonstrate the Use of the Data Simulator in the Optima™ XL-A/XL-I Data Analysis Software |
A-1847B |
|
|
a-Chymotrypsin: Characterization of a Self-Associating System in the Analytical Ultracentrifuge |
T-1782A |
|
|
A Robust cIEF Method: Intermediate Precision for the pH 5-7 Range |
A-12015A (PL) |
|
|
Analysis of Membrane Protein Dimerization by Sedimentation Equilibrium |
A-1855A |
|
|
Assay of IgG Purity and Heterogeneity Using High-Resolution Sodium Dodecyl Sulfate Capillary Gel Electrophoresis |
A-1973A |
|
|
CE Separation of N-linked Oligosaccharides released from Recombinant Monoclonal Antibody |
A-1986A |
|
|
Capillary Isoelectric Focusing with the ProteomeLab PA 800 for the Characterization of a Recombinant Monoclonal Antibody |
A-1977A |
|
|
Choosing Which Optical System of the Optima™ XL-I Analytical Ultracentrifuge to Use (Available as PDF only) |
A-1821A |
|
|
Comprehensive Mapping of Protein Expression Profiles in Activated and Non-Activated Peripheral Blood Mononuclear Cells |
A-1972A |
|
|
Detecting the Presence of Abnormal Prion Protein from Blood: Clearing a Major Analytical Hurdle |
A-1870A |
|
|
Determination of Molecular Weight of Glycoproteins by Analytical Ultracentrifugation |
DS-837 |
|
|
High-Resolution cIEF of Therapeutic Monoclonal Antibodies: A Platform Method Covering pH 4-10 |
A-12026A (PL) |
|
|
Identification of System Parameters Critical for High-Performance cIEF |
A-11634A (PL) |
|
|
NanoOrange Protein Quantitation with the Beckman Coulter DTX 800/880 Multimode Detector |
A-2006A |
|
|
Overview of Sedimentation Velocity for the Optima™ XL-A Analytical Ultracentrifuge |
DS-819 |
|
|
Peptide Mapping with the ProteomeLab™ PA 800 |
A-1976A |
|
|
Proteome Analysis of Human Plasma with the ProteomeLab™ PF 2D System |
A-1963A |
|
|
ProteomeLab™ PF 2D Analysis of Genetically-Characterized Human Glioma Xenografts |
A-1971A |
|
|
ProteomeLab™ PF 2D Analysis of Gliomas Treated with Novel Platinum Compounds |
A-1970A |
|
|
Purification of Transferrin Isoforms from Serum prior to Analysis with Capillary Electrophoresis |
A-10808A |
|
|
Rapid Determination of Spectrophotometric Absorptivity by Analytical Ultracentrifugation |
A-1815A |
|
|
Short Column Sedimentation Equilibrium Analysis for Rapid Characterization of Macromolecules in Solution |
DS-835 |
|
|
Stability of the Human Immunodeficiency Virus-1 Reverse Transcriptase Heterodimer. |
A-1807A |
|
|
The Solution Conformation of Novel Antibody Fragments Studied Using the Optima™ XL-A Analytical Ultracentrifuge |
DS-834 |
|
|
Using the Biomek® 3000 Laboratory Automation Workstation to Interface the ProteomeLab™ PF 2D System with the MALDI-TOF MS for Multidimensional Proteome Profiling |
A-1987A(PL) |
|
|
Using the Biomek® FX Laboratory Automation Workstation to Interface the ProteomeLab™ PF 2D System with the MALDI-TOF MS for Multidimensional Proteome Profiling |
A-1988A(PL) |
|
|
Validation of Multiplexed IgY-12 Immunoaffinity Column Chromatography for Discovery of Low Abundant Plasma Proteins Using iTRAQ Quantitative Proteomic Analysis |
A-10701A |
--
Publication is online in HTML format.
--
Publication not available online but can be ordered from Beckman Coulter
or through your local Beckman Coulter representative.